The naming of brands is a difficult matter.
While preventive care is vital to the well-being of all types of patients, members of the lesbian, gay, bisexual, transgender and queer and/or questioning community face unique barriers that impact their preventive health awareness and access – setting many of them up for poorer overall health outcomes and even impacting their trust in pharma.
ANI Pharmaceuticals shares how a data-driven go-to-market approach can help lean teams effectively launch and grow rare diseases brands.
The looming reality of health inequity and how healthcare communicators can help fight against it
Johnson & Johnson will stop selling talc-based baby powder globally in 2023, the drugmaker said on Thursday, more than two years after it ended U.S. sales of a product that drew thousands of consumer safety lawsuits.
Greater Than One, a privately held agency focused on healthcare, announced that Mindy Telmer has been appointed executive creative director, EVP. Telmer will be the creative voice of the agency, responsible for providing Greater Than One clients with strategic creative direction and oversight from inception through execution. Telmer will report directly to Matthew Howes, president of Greater Than One.
Q&A with Michael Dunn of Genentech
The latest acquisition expands Spectrum’s global capabilities, and provides enhanced resources, expertise and experience to award-winning Aurora team.
Federal regulation of data privacy and security has been on the back burner for the past two years, but key members of Congress have been working behind the scenes to frame bipartisan legislation and the FTC is gearing up. The Supreme Court’s decision overturning Roe v. Wade may put this issue front and center in Congress after the midterms.
Can decentralized and agile approaches also be applied to LTFUs and the collection of real-world evidence (RWE)? What does that look like, who’s interested in pursuing it, and what are the perceived benefits and pitfalls?
